yahoo_financeOriginal article
Inventiva Says All Patients Completed 72-Week Treatment Period in Phase 3 Liver Disease Study
Phase 3Positive
AI Analysis
Summary
Inventiva announced that all patients have completed the 72-week treatment period in its Phase 3 liver disease study. The company has reached a procedural milestone in the trial.
Clinical Trial Data
Phase
Phase 3
Outcome Details
all patients completed 72-week treatment period
Importance:5/10
Sentiment:
0.40
Phase 3liver diseaseclinical trial milestone
Related Companies
Read the original article
Published by yahoo_finance on September 2, 2026 9:44 PM